Aging and Disease · 2021 · 80 citations · 45 references
Life SciencesImmunologyInfectious DiseasesImmunoregulationImmunotherapyInflammationCell-mediated ImmunityImmune RegulationImmune-mediated DiseaseRegulatory T Cell DysfunctionRegulatory T CellsT Cell BiologyImmune System DisruptionImmune System ModulationPeripheral Regulatory T CellsSars-cov-2 InfectionSevere Acute Respiratory SyndromeT Cell-mediated InflammationT-cell Mediated InflammationT-cell Mediated Responses
The outbreak of coronavirus disease 2019 (COVID-19) is caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to the disruption of immune system, exacerbated inflammation, and even multiple organ dysfunction syndrome. Regulatory T cells (Tregs) are an important subpopulation of T cells that exert immunosuppressive effects. Recent studies have demonstrated that the number of Tregs is significantly reduced in COVID-19 patients, and this reduction may affect COVID-19 patients on several aspects, such as weakening the effect of inflammatory inhibition, causing an imbalance in Treg/Th17 ratio, and increasing the risk of respiratory failure. Treg-targeted therapy may alleviate the symptoms and retard disease progression in COVID-19 patients. This study highlights the recent findings on the involvement of Tregs in the regulation of immune responses to COVID-19, and we hope to provide novel perspectives on the alternative immunotherapeutic strategies for this disease that is currently prevalent worldwide.
45
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu et al. · Cell · 2020 · 4.5K citations · Full text